Bionano Genomics, Inc. (BNGO)
| Previous Close | 1.7700 |
| Open | 1.8000 |
| Bid | 1.6800 x 36900 |
| Ask | 1.6900 x 2900 |
| Day's Range | 1.6800 - 1.7900 |
| 52 Week Range | 1.1600 - 4.3500 |
| Volume | |
| Avg. Volume | 7,446,939 |
| Market Cap | 506.257M |
| Beta (5Y Monthly) | 2.26 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
Bionano’s Symposium 2023 Featured Record Numbers of Presentations Demonstrating Applications of OGM Across Cell Bioprocessing and Constitutional Genetic Disease and Cancer Research
Over 3,000 registrants with attendees from 114 countriesAverage daily attendance of 750 in 2023 versus 565 in 202231 oral presentations delivered across four consecutive days69 scientific posters featuring optical genome mapping (OGM) on view in the online exhibit hallOn-demand presentations from Symposium available for remainder of 2023 SAN DIEGO, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO) today announced the conclusion of Bionano’s 2023 Symposium, which was held January 23
- GlobeNewswire
Bionano Laboratories Expands its Clinical Testing Menu with Launch of its First OGM-Based Laboratory Developed Test (LDT) for Hematological Malignancies
SAN DIEGO, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Bionano Laboratories today announced the launch of OGM-Dx™ HemeOne™, a laboratory developed test (LDT) based on optical genome mapping (OGM) analysis of blood or bone marrow samples to detect structural variants (SVs) of diagnostic and prognostic utility in individuals with a new or an existing diagnosis of a hematological malignancy. Compared to traditional cytogenetic methods, this OGM-based assay offers a streamlined and improved workflow to assess
- GlobeNewswire
Bionano Announces Launch of Next-Generation Versions of its Reagent Kits and Chip Consumable, Along with Updates to its Instrument Control and Bionano Access Software for the Optical Genome Mapping Workflow
Bionano Prep SP-G2 (SP-G2) kit offers higher gDNA quality, improved ease-of-use and increased DNA throughputBionano Prep Direct Label and Stain-G2 (DLS-G2) kit offers increased reagent stability and labeling efficiency resulting in significantly faster sample to results workflowSaphyr Chip® G3.3, instrument control software (ICS) version 5.3 and Bionano Access™ software version 1.7.2 offer enhanced evaporation control and workflow robustness enabling for more high coverage samples to be run per
